AGLE - Aeglea -5% amid $100M equity offering April, 27 2020 06:47 PM Aeglea BioTherapeutics Inc. Aeglea BioTherapeutics (NASDAQ:AGLE) is 5% lower postmarket after word that it's filed to offer $100M in equity.More news on: Aeglea BioTherapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...